Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALBO

Albireo Pharma

$24.13

0.16 (0.67%)

09:08
01/22/19
01/22
09:08
01/22/19
09:08
Hot Stocks
Albireo Pharma announces orphan drug designation for A4250 »

Albireo Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Thursday
ALBO

Albireo Pharma

$24.54

0.08 (0.33%)

12:03
01/17/19
01/17
12:03
01/17/19
12:03
Hot Stocks
Albireo Pharma treatment of biliary atresia granted FDA orphan status »

Albireo Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ALBO

Albireo Pharma

$23.74

0.33 (1.41%)

08:36
12/18/18
12/18
08:36
12/18/18
08:36
Hot Stocks
Albireo Pharma receives orphan designation for A4250 from European Commission »

Albireo Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALBO

Albireo Pharma

$24.98

0.07 (0.28%)

10:25
11/14/18
11/14
10:25
11/14/18
10:25
Conference/Events
Albireo Pharma to participate in a conference call with William Blair »

Conference call with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

ALBO

Albireo Pharma

$24.91

0.61 (2.51%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
Albireo Pharma to participate in a conference call with William Blair »

Conference call with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

ALBO

Albireo Pharma

$24.30

(0.00%)

, ALLK

Allakos

$55.66

(0.00%)

09:40
11/13/18
11/13
09:40
11/13/18
09:40
Conference/Events
William Blair to hold a conference »

Biotech Focus Day Series…

ALBO

Albireo Pharma

$24.30

(0.00%)

ALLK

Allakos

$55.66

(0.00%)

RVNC

Revance

$22.60

(0.00%)

UBX

Unity Biotechnology

$12.17

(0.00%)

VKTX

Viking Therapeutics

$11.73

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 27

    Nov

ALBO

Albireo Pharma

$26.10

-1.86 (-6.65%)

14:59
11/09/18
11/09
14:59
11/09/18
14:59
Conference/Events
Albireo Pharma to participate in a conference call with William Blair »

Conference call with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

ALBO

Albireo Pharma

$29.00

-0.01 (-0.03%)

12:25
11/05/18
11/05
12:25
11/05/18
12:25
Conference/Events
Albireo Pharma to participate in a conference call with William Blair »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ALBO

Albireo Pharma

$29.01

(0.00%)

09:49
11/05/18
11/05
09:49
11/05/18
09:49
Conference/Events
Albireo Pharma to participate in a conference call with William Blair »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ALBO

Albireo Pharma

$28.43

0.47 (1.68%)

08:35
10/17/18
10/17
08:35
10/17/18
08:35
Hot Stocks
Albireo Pharma announces fast track designation for A4250 from FDA »

Albireo Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.